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ABSTRACT
Objective: Laparoscopic adrenalectomy is widely recog-
nized as the preferred technique for surgical removal of
adrenal masses. This study aimed to evaluate the out-
comes of consecutive laparoscopic adrenalectomies per-
formed at a high-volume referral center and compare
operative results for pheochromocytomas with that of
other adrenal diseases.
Materials and Methods: We retrospectively reviewed a
single surgeon’s experience with laparoscopic adrenalec-
tomy performed between July 2002 and June 2007. Patient
records were analyzed in regards to demographics, pa-
thology diagnoses, operative time, postoperative compli-
cations, tumor size, hospital stay, among others.
Results: Seventy-two consecutive laparoscopic adrena-
lectomies were performed on 70 patients, including 2
bilateral adrenalectomies and one partial adrenalectomy.
Surgical indications included pheochromocytoma (n11),
aldosteronoma (n26), malignant adrenal disease (n4),
nonfunctioning adenomas (n17), Cushing’s disease
(n6), and other adrenal disease (n8). No mortality was
observed. Perioperative complications occurred in 7 cases
(9.7%). When a comparison between pathological diag-
nosis groups was made, no statistical differences were
seen between pheochromocytomas and other adrenal
neoplasms with respect to estimated blood loss, open
conversion rate, length of stay, preoperative and postop-
erative hemoglobin values, blood transfusion rates, peri-
operative complication occurrence, tumor size, and ASA
class.
Conclusion: Laparoscopic adrenalectomy is a safe and
appropriate surgical technique for most adrenal lesions,
including pheochromocytomas.
Key Words: Adrenal tumor, Adrenal adenoma, Adreno-
cortical carcinoma, Laparoscopic adrenalectomy, Hyper-
tension, Aldosteronoma, Pheochromocytoma.
INTRODUCTION
Since its first report in 1992, laparoscopic adrenalectomy
(LA) has increasingly become the preferred operative ap-
proach for adrenal disease.1 Difficulty with open surgical
exposure and the small size of the adrenal gland make this
organ particularly amenable to a minimally invasive ap-
proach.2 Additionally, numerous studies have demon-
strated clear advantages to this technique in regards to
decreased intraoperative blood loss, shorter operative
times and hospital stays, reduced narcotic requirements,
and earlier return to normal activity and diet.3–6 Current
widely accepted indications for LA include aldoster-
onoma, nonfunctioning adenomas, bilateral adrenal hy-
perplasia, and less common cysts and myelolipomas.7
Though initially there was debate regarding the use of LA
for pheochromocytoma because of concerns for hemody-
namic instability due to catecholamine release during tu-
mor manipulation, the laparoscopic approach has now
been adopted for most pheochromocytomas today.8,9 The
aim of this study was to assess the contemporary out-
comes of LA for an individual surgeon at a high-volume
referral center. Further, we compare the safety and effi-
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SCIENTIFIC PAPERPreoperative Evaluation
Adrenal masses were localized by computed tomography
or magnetic resonance imaging. Preoperative endocrine
assessment included laboratory testing, history and phys-
ical examination, biochemical screening for urinary and
serum catecholamine or metanephrine expression. All
pheochromocytomas were treated preoperatively with a
selective alpha-receptor blocker. Beta-receptor blocking
agents were also used in those patients with tachya-
rrhymia under concurrent alpha blockade.
Operative Technique
All patients for unilateral adrenalectomy underwent a
transperitoneal lateral approach to laparoscopic adrenal-
ectomy. After the patient was placed in a lateral decubitus
position, two 5-mm trocars for the working instruments
and a 12-mm trocar for the laparoscope were introduced.
On the right side, a fourth 5-mm port was inserted in the
epigastrium for liver retraction. Another 5-mm trocar was
often used in the subcostal region at the anterior axillary
line for lateral retraction. During left LA, the retroperito-
neum was exposed by incising along the descending
colon from the splenic flexure to below the kidney. For
right-sided procedures, the retroperitoneum was accessed
by incising the peritoneum just below the inferior liver
edge and exposing the inferior vena cava. The duodenum
was often mobilized. In each case, correct identification of
the vasculature was confirmed prior to isolation and clip-
ping of the adrenal vein. The crucial step of dividing the
adrenal vein is always accomplished before gland dissec-
tion to avoid troublesome bleeding or catecholamine re-
lease. Ultrasonic shears and bipolar forceps were used for
dissection and hemostasis. The medial and inferior adre-
nal dissections were initially accomplished. The adrenal
gland was subsequently dissected free and placed in an
Endopouch. The operative field was inspected for hemo-
stasis, and the pneumoperitoneum was decompressed.
The specimen was extracted via extension of the 12-mm
port site.
Follow-up
All patients underwent short-term follow-up with an out-
patient clinic visit 3 weeks to 4 weeks following hospital
discharge. In addition, for those requiring long-term ob-
servation, annual office visits were scheduled, and in
select patients, abdominal imaging was performed. Pa-
tients with functioning neoplasms were followed serially
by their endocrinologist who routinely performed indi-
cated laboratory analysis.
Statistical Analysis
The chi-square test was used to compare categorical data.
It was used to compare categorical differences between
LA groups based on pathological diagnosis. The Mann-
Whitney test was used to compare LAs performed for
pheochromocytomas versus other adrenal disease (OAD)
as a whole. P0.05 was considered statistically significant.
RESULTS
Between July 2002 and June 2007, a total of 72 consecu-
tive transperitoneal laparoscopic adrenalectomies were
performed. Patient demographics are displayed in Table
1. The mean age of all patients was 54 years (range, 27 to
77). The male to female ratio was approximately 1.33:1.
Thirty-six LAs were performed on the left, 32 on the right,
and 2 patients underwent bilateral adrenalectomies. No
mortality was observed. Open conversion occurred in one
patient (1.4%) secondary to adhesions from a previous
laparotomy. In this case, significant blood loss or other
Table 1.
Patient Demographics
Patients Pheochromocytoma Adenoma Conn’s Cushing’s Malignancy Other
Total (n) 11 17 26 4 4 8
Female 4 11 6 2 1 6
Male 7 6 20 2 2 3
Mean Age (y, range) 57.3 (32–76) 54.8 (27–74) 52.8 (34–77) 60.3 (54–72) 45.3 (28–62) 49.6 (30–72)
Side
Right 6 8 12 1 1 4
Left 5 9 14 1 3 4
Bilateral 0 0 0 2 0 0
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charged home on postoperative day 4. Also, one patient
with symptoms of Conn’s disease underwent right-sided
partial LA. This was performed without complication, and
the patient was discharged home the next day.
The results of the comparison between LA for pheochro-
mocytomas versus OAD are shown in Table 2. Our study
demonstrated no statistically significant differences be-
tween these groups with respect to operative time, EBL,
open conversion rate, length of stay, preoperative and
postoperative hemoglobin values, blood transfusion rates,
perioperative complication occurrence, tumor size, and
intraoperative average blood pressures and ASA class.
Additionally, patients undergoing pheochromocytoma re-
sections did not routinely receive intensive care unit (ICU)
admission for blood pressure monitoring.
Perioperative complications occurred in 7 cases (9.7%).
These are listed in Table 3 and classified according to
Clavien’s modified scale.10 A small transmural perforation
of the descending colon occurred during a left LA for
adrenocortical carcinoma diagnosed postoperatively. The
injury was immediately recognized. An intraoperative
general surgery consult was obtained, and the injury was
repaired laparoscopically without complication. The ad-
renalectomy was completed, and the patient was dis-
charged 5 days later. To date, there have been no onco-
logic recurrences. One individual with cystic fibrosis
developed a severe pulmonary exacerbation requiring
postoperative intubation and prolonged ICU stay after a
right LA for an enlarging adrenal pseudocyst. A fifth pa-
tient underwent an unremarkable left adrenalectomy but
developed a prolonged ileus and renal failure secondary
to hypovolemia. After aggressive resuscitation, the pa-
tient’s renal function returned to baseline, and he was
discharged on POD 7 without sequelae. An additional 4
patients required one unit blood transfusions for symp-
tomatic anemia. Otherwise, their hospital course was un-
remarkable, and no further intervention was required.
The mean follow-up evaluation was 27.4 months (range, 1
to 61). To date, no pheochromocytomas have recurred.
Four patients were treated for malignant diseases, 3 adre-
nocortical carcinomas and one metastatic melanoma. In
the follow-up of these patients, no recurrences have been
noted. No patients with aldosteronomas had an elevated
serum aldosterone level at standard 4-week follow-up.
DISCUSSION
The validity of laparoscopy for the spectrum of adrenal
disease has been widely accepted. In this study, we ret-
rospectively compared operative outcomes for patients
who underwent LA based on pathological diagnosis
groups. In particular, we investigated whether differences
existed between pheochromocytomas and other adrenal
diseases. Our data analysis demonstrated no statistical
differences between patients with pheochromocytomas
and those with OAD based on a number of operative
parameters. Importantly, laparoscopic dissection did not
represent significant cardiovascular problems in our se-
ries. Although our data show no difference in intraoper-
ative average maximum and minimum SBP between
pheochromocytomas and other diagnoses (P0.291 and
0.197, respectively), only 6 of 11 pheochromocytomas had
significantly elevated preoperative catecholamines and
may explain these results. Some investigators have sug-
gested that a laparoscopic approach to pheochromocy-
toma decreases the intraoperative release of cat-
echolamines compared with open surgery, thus reducing
the risk of a hypertensive crisis.11 A recent study in a large
number of patients confirmed that laparoscopic adrenal-
ectomy for pheochromocytoma was superior to the tradi-
tional open approach for intraoperative control of blood
pressure.12 This may be directly related to operative time
as some groups have reported longer procedure times
when performing open versus laparoscopic adrenalecto-
mies for pheochromocytomas.13,14 If this holds true, an
Table 2.
Comparison of Laparoscopic Adrenalectomy for






Operating Time (min) 181.4 174.4 0.165
EBL* (mL) 34.6 63.1 0.929
Open Conversion 0 1 0.664
LOS* (days) 1.8 2.1 0.710
Maximum SBP (mm Hg) 140.0 143.4 0.291
Minimum SBP (mm Hg) 97.7 102.9 0.197
Preop Hb (g) 12.8 13.7 0.411
Postop Hb (g) 11.7 12.4 0.068
Blood Transfusion 1 1 0.177
Minor Complications 1 6 0.939
Tumor Size (cm) 3.5 3.7 0.453
ASA Class 2.9 2.8 0.570
*EBLestimated Blood Loss; LOSlength of stay; Pheo
pheochromocytomas; OADother adrenal diseases.
Laparoscopic Adrenalectomy for Pheochromocytoma Versus Other Surgical Indications, Mellon MJ et al
JSLS (2008)12:380–384 382experienced laparoscopic surgeon can significantly re-
duce the risk of resection for these tumors. In our study,
average operative time for pheochromocytomas of 181.4
minutes was not statistically significant from OAD time of
174.8 minutes (P0.165). Furthermore, we agree with
others that central to reducing the risk of excessive cate-
cholamine secretion during surgery is early ligation of the
adrenal vein.15,16 In our experience, this step was per-
formed before dissection of the gland and along with
minimizing adrenal manipulation, likely explains the lack
of hypertensive crises in this series. We also believe lapa-
roscopy affords improved visualization and faster access
to the adrenal vein, further reducing the risk of catechol-
amine release.
Additionally, our complication rate of 9.1% for pheochro-
mocytomas was not statistically different from that of
other adrenal diagnoses (P0.939). We cannot stress
enough that essential factors for successful and safe re-
section of these lesions are the presence of an experi-
enced anesthesiology team, precise localization of the
tumor, and appropriate preoperative medical manage-
ment and preparation. We caution that in our series the
average tumor size of the pheochromocytomas was 3.5
cm. Debate still remains over acceptable pheochromocy-
toma sizes appropriate for laparoscopic removal. Some
believe that tumors larger than 6 cm pose increased risk
for malignancy and should be deemed a contraindication
to a minimally invasive approach.17,18 Furthermore, in a
13-year review of 456 laparoscopic adrenalectomy cases,
tumor size 5 cm, BMI24 kg/m
2, and pheochromocy-
tomas were predictors for open conversion.19 In our se-
ries, the 4 malignant adrenal lesions via LA had a mean
size of 4.92.1 cm. Of note, 2 of these masses were
believed to be nonfunctioning adenomas prior to resec-
tion and pathologically diagnosed postoperatively. We
agree that larger lesions pose a greater operating chal-
lenge. Though size is not an absolute contraindication,
preoperative imaging plays an even greater role in deter-
mining the appropriate surgical approach. Thus, proper
localization and careful patient selection can yield accept-
able results. In our series, 9 of 11 patients were cured of
their hypertension (81.8%) upon an average follow-up of
29.4 months (range, 3 to 58), and no patients displayed
radiographic evidence of pheochromocytoma metastases
or local recurrence.
A limitation of this study is the inherent selection bias of a
retrospective review. Our goal was to compare outcomes
of LA for pheochromocytomas with outcomes of other
adrenal diseases. We chose to include consecutive pa-
tients during a short time period. All procedures were
performed later in the surgeon’s experience and therefore
reflect minimal learning curve effects. Though there were
no statistical differences noted in operative parameters,
the modest number of total pheochromocytomas resected
(n11) may restrict our interpretation and should be con-
sidered a limitation of this study.
CONCLUSIONS
Laparoscopic adrenalectomy is a safe and appropriate
surgical technique for most adrenal lesions. In particular,
pheochromocytomas should be considered for this ap-
proach. Our results with 72 consecutive LAs demonstrate
that excellent postoperative outcomes can be expected
regardless of pathologic diagnosis. There is no difference
between surgical outcomes following laparoscopic adre-
nalectomy for pheochromocytomas and outcomes follow-
ing other indications for surgery.
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